Evidence map›Paper›PMID 32163420›Full record

ArticlePLoS neglected tropical diseases2020

Prevalence of chronic chikungunya and associated risks factors in the French West Indies (La Martinique): A prospective cohort study.

Antoine Bertolotti, Marême Thioune, Sylvie Abel, Gilda Belrose, Isabelle Calmont, Raymond Césaire, Minerva Cervantes, Laurence Fagour, Émilie Javelle, Catherine Lebris and 7 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01099852 (Descriptive and Prognostic Study of Arbovirus Infections in France, Based on a Hospital Cohort of Children and Adults With Suspected Arbovirose.), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01099852 unknown statusnot on this map

Descriptive and Prognostic Study of Arbovirus Infections in France, Based on a Hospital Cohort of Children and Adults With Suspected Arbovirose.

TypeobservationalSponsorUniversity Hospital Center of MartiniqueRan2010 to 2023Enrolled1,377ConditionsFever, Dengue, Chikungunya, Zika VirusArmsbiological sample collection, Quality of life Questionnaire EuroQol®, Health Assessment Questionnaire - MDHAQ and RAPID3, Neuropathic Pain Questionnaire (DN4)
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Barcoding Quantitative PCR Assay to Distinguish BetweenTropical medicine and infectious disease · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 3 countries.

Antoine BertolottiINSERM, CIC1410, CHU de la Réunion, Saint-Pierre, France.ORCID 0000-0003-3962-8869
Marême ThiouneCHU de Martinique, service de maladies infectieuses et tropicales, Fort-de-France, France.
Sylvie AbelCHU de Martinique, service de maladies infectieuses et tropicales, Fort-de-France, France.
Gilda BelroseCHU de Martinique, Centre de ressource biologique de la Martinique, Fort-de-France, France.
Isabelle CalmontINSERM, CIC1424, CHU de Martinique, Fort-de-France, France.
Raymond CésaireUniversité des Antilles, EA 4537, Fort-de-France, France.
Minerva CervantesINSERM, IAME, UMR 1137; Université Paris Diderot, Paris, France.
Laurence FagourCHU de Martinique, laboratoire de virologie, Fort-de-France, France.
Émilie JavelleHôpital d'instruction des Armées Laveran, service de pathologie infectieuse et tropicale, Marseille, France; Aix Marseille Université, Institut de Recherche pour le Développement (IRD); Assistance Publique-Hôpitaux de Marseille, Microbes Vecteurs Infections Tropicales et Méditerranéennes (VITROME); Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France.
Catherine LebrisCHU de Martinique, service de maladies infectieuses et tropicales, Fort-de-France, France.
Fatiha NajioullahUniversité des Antilles, EA 4537, Fort-de-France, France.
Sandrine Pierre-FrançoisCHU de Martinique, service de maladies infectieuses et tropicales, Fort-de-France, France.
Benoît RozéCHU de Martinique, service de maladies infectieuses et tropicales, Fort-de-France, France.
Marie ViganINSERM, CIC-EC 1425, Hôpital Bichat, Paris, France.
Cédric LaouénanINSERM, IAME, UMR 1137; Université Paris Diderot, Paris, France.
André CabiéCHU de Martinique, service de maladies infectieuses et tropicales, Fort-de-France, France.ORCID 0000-0003-0117-3061
Chronic Chikungunya working group of University Medical Center of Martinique
Centre Hospitalier Universitaire de Martinique · MQInserm · FRAix-Marseille Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe chikungunya virus (CHIKV) is a re-emerging alphavirus that can cause chronic and potentially incapacitating rheumatic musculoskeletal disorders known as chronic chikungunya arthritis (CCA). We conducted a prospective cohort study of CHIKV-infected subjects during the 2013 chikungunya outbreak in Martinique. The aim of this study was to assess the prevalence of CCA at 12 months and to search for acute phase factors significantly associated with chronicity. METHODOLOGY/PRINCIPAL

findingsA total of 193 patients who tested positive for CHIKV RNA via qRT-PCR underwent clinical investigations in the acute phase (<21 days), and then 3, 6, and 12 months after inclusion. The Asian lineage was identified as the circulating genotype. A total of 167 participants were classified as either with or without CCA, and were analyzed using logistic regression models. The overall prevalence of CCA at 12 months was 52.1% (95%CI: 44.5-59.7). In univariate analysis, age (RD 9.62, 95% CI, 4.87;14.38, p<0.0001), female sex (RD 15.5, 95% CI, 1.03;30.0, p = 0.04), headache (RD 15.42, 95% CI, 0.65;30.18 p = 0.04), vertigo (RD 15.33, 95% CI, 1.47;29.19, p = 0.03), vomiting (RD 12.89, 95% CI, 1.54;24.24, p = 0.03), dyspnea (RD 13.53, 95% CI, 0.73;26.33, p = 0.04), intravenous rehydration (RD -16.12, 95% CI, -31.58; -0.66 p = 0.04) and urea (RD 0.66, 95% CI, 0.12;1.20, p = 0.02) were significantly associated with the development of CCA. For the subpopulation with data on joint involvement in the acute phase, the risk factors significantly associated with CCA were at least one 1 enthesitis (RD 16.7, 95%CI, 2.8; 30.7, p = 0.02) and at least one tenosynovitis (RD 16.8, 95% CI, 1.4-32.2, p = 0.04).

conclusionsThis cohort study conducted in Martinique confirms that CCA is a common complication of acute chikungunya disease. Our analysis emphasized the importance of age and female sex for CCA occurrence, and highlighted the aggravating role of dehydration during the acute phase. Early and adequate hydration were found to reduce the risk chronic chikungunya disorders.

trial registrationclinicaltrials.gov (NCT01099852).

Indexed as

AdultAgedAged, 80 and overArthritisChikungunya FeverChikungunya virusChronic DiseaseFemaleFollow-Up StudiesGenotypeHumansMaleMartiniqueMiddle AgedPrevalencePrognosisRNA, Viral

Identifiers

PMID32163420
PMCPMC7100975
OpenAlexW3012010185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.